denosumab-qbde

denosumab-qbde (ENOBY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

ENOBY is a marketed brand name for denosumab-qbde. Check FDA Drugs@FDA for the current US label holder and prescribing information.

denosumab-qbde has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.